Vandazole patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7456207 TEVA PHARMS Vaginal pharmaceutical compositions and methods for preparing them
Sep, 2024

(11 months from now)

Vandazole is owned by Teva Pharms.

Vandazole contains Metronidazole.

Vandazole has a total of 1 drug patent out of which 0 drug patents have expired.

Vandazole was authorised for market use on 20 May, 2005.

Vandazole is available in gel;vaginal dosage forms.

The generics of Vandazole are possible to be released after 22 September, 2024.

Drugs and Companies using METRONIDAZOLE ingredient

Market Authorisation Date: 20 May, 2005

Treatment: NA


More Information on Dosage

VANDAZOLE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic